60
Participants
Start Date
March 3, 2025
Primary Completion Date
October 31, 2028
Study Completion Date
October 31, 2028
Pumitamig
Intravenous infusion
Docetaxel
Intravenous infusion
RECRUITING
Cancer Research SA (CRSA), Adelaide
RECRUITING
NYU Langone - NYU Grossman School of Medicine, New York
RECRUITING
Gachon University Gil Medical Center, Incheon
RECRUITING
Chungbuk National University Hospital, Cheongju-si
RECRUITING
Moffitt Cancer Center, Tampa
RECRUITING
Baptist Health Hardin, Elizabethtown
RECRUITING
Gyeongsang National University Hospital (GNUH), Jinju
ACTIVE_NOT_RECRUITING
Texas Oncology, P.A., Houston
RECRUITING
Samsung Medical Center, Seoul
RECRUITING
Velindre NHS Trust, Velindre Cancer Centre, Cardiff
RECRUITING
St James's University Hospital - Leeds Teaching Hospitals NHS Trust, Leeds
RECRUITING
Sarah Cannon Research Institute, London
Lead Sponsor
BioNTech SE
INDUSTRY